Form 4: Merit Medical Systems Director Thomas James Gunderson Reports Stock Transactions

Sentiment:

SEC Form 4


Director Thomas James Gunderson of Merit Medical Systems reports the acquisition and disposal of company stock and derivative securities.

Summary

  • On February 28, 2025, Thomas James Gunderson, a director of Merit Medical Systems Inc. (MMSI), engaged in transactions involving the company's common stock and non-qualified stock options.
  • Gunderson exercised non-qualified stock options to acquire 25,000 shares of common stock at a price of $50.50 per share.
  • He then disposed of 12,806 shares of common stock at a weighted average price of $99.95, with prices ranging from $98.60 to $100.515.
  • Following these transactions, Gunderson beneficially owns 33,882 shares of common stock directly.
  • He also holds non-qualified stock options for 13,750 shares exercisable from 05/24/2020 and 7,500 shares exercisable from 05/31/2020.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key individuals within the company.

Stakeholder Impact

  • Shareholders may be interested in the trading activity of company insiders as it can provide insights into their perspective on the company's value and future prospects.

Key Dates

DateDescription
06/07/2019Date when non-qualified stock options become exercisable in equal annual installments of 20%.
05/24/2020Date when non-qualified stock options become exercisable in equal annual installments of 33%.
05/31/2020Date when non-qualified stock options become exercisable in equal annual installments of 33%.
02/28/2025Date of the reported transactions: stock option exercise and stock disposal.
03/03/2025Date of signature by Attorney-in-Fact.
05/24/2026Expiration date for non-qualified stock options.
05/31/2026Expiration date for non-qualified stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.